İDİLMAN, R. Et Al. 2019. Low recurrence rate of hepatocellular carcinoma following ledipasvir and sofosbuvir treatment in a real-world chronic hepatitis C patients cohort. JOURNAL OF VIRAL HEPATITIS , vol.26, no.6 , 666-674.

İDİLMAN, R., DEMİR, M., ALADAĞ, M., Erol, C., Cavus, B., Iliaz, R., ... Koklu, H.(2019). Low recurrence rate of hepatocellular carcinoma following ledipasvir and sofosbuvir treatment in a real-world chronic hepatitis C patients cohort. JOURNAL OF VIRAL HEPATITIS , vol.26, no.6, 666-674.

İDİLMAN, RAMAZAN Et Al. "Low recurrence rate of hepatocellular carcinoma following ledipasvir and sofosbuvir treatment in a real-world chronic hepatitis C patients cohort," JOURNAL OF VIRAL HEPATITIS , vol.26, no.6, 666-674, 2019

İDİLMAN, RAMAZAN Et Al. "Low recurrence rate of hepatocellular carcinoma following ledipasvir and sofosbuvir treatment in a real-world chronic hepatitis C patients cohort." JOURNAL OF VIRAL HEPATITIS , vol.26, no.6, pp.666-674, 2019

İDİLMAN, R. Et Al. (2019) . "Low recurrence rate of hepatocellular carcinoma following ledipasvir and sofosbuvir treatment in a real-world chronic hepatitis C patients cohort." JOURNAL OF VIRAL HEPATITIS , vol.26, no.6, pp.666-674.

@article{article, author={RAMAZAN İDİLMAN Et Al. }, title={Low recurrence rate of hepatocellular carcinoma following ledipasvir and sofosbuvir treatment in a real-world chronic hepatitis C patients cohort}, journal={JOURNAL OF VIRAL HEPATITIS}, year=2019, pages={666-674} }